Consilient Health’s BD teams are actively seeking new strategic alliances so giving our partners access to countries within Europe, Middle East and Africa, in turn, giving patients access to their medicines.

The team is broadly split into two with either a branded pharmaceutical or a generic focus but there is close collaboration and we are keen to take a best for brand approach. The team is cross functional and encompasses BD, marketing, commercial, regulatory, medical and operational knowledge as well as experience across a wide range of therapeutic areas. Our highly experienced Non-Executive Directors act as advisors to the team. The team undertake robust analyses and commit to providing solid decisions in a timely manner.